Organoclick (Sweden) Buy Hold or Sell Recommendation
| ORGC Stock | SEK 2.82 0.01 0.35% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Organoclick AB is 'Cautious Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Organoclick AB given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Organoclick AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Organoclick Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Organoclick and provide practical buy, sell, or hold advice based on investors' constraints. Organoclick AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Organoclick |
Execute Organoclick Buy or Sell Advice
The Organoclick recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Organoclick AB. Macroaxis does not own or have any residual interests in Organoclick AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Organoclick's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Organoclick Trading Alerts and Improvement Suggestions
| Organoclick AB generated a negative expected return over the last 90 days | |
| Organoclick AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Organoclick AB has accumulated 24.85 M in total debt with debt to equity ratio (D/E) of 198.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Organoclick AB has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Organoclick until it has trouble settling it off, either with new capital or with free cash flow. So, Organoclick's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Organoclick AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Organoclick to invest in growth at high rates of return. When we think about Organoclick's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 110.06 M. Net Loss for the year was (32.69 M) with profit before overhead, payroll, taxes, and interest of 18.51 M. | |
| Organoclick AB has accumulated about 34.25 M in cash with (37.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. | |
| Roughly 35.0% of Organoclick outstanding shares are owned by corporate insiders |
Organoclick Returns Distribution Density
The distribution of Organoclick's historical returns is an attempt to chart the uncertainty of Organoclick's future price movements. The chart of the probability distribution of Organoclick daily returns describes the distribution of returns around its average expected value. We use Organoclick AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Organoclick returns is essential to provide solid investment advice for Organoclick.
| Mean Return | -0.12 | Value At Risk | -3.45 | Potential Upside | 3.10 | Standard Deviation | 2.52 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Organoclick historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Organoclick Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Organoclick or Basic Materials sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Organoclick's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Organoclick stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.18 | |
β | Beta against Dow Jones | 0.42 | |
σ | Overall volatility | 2.54 | |
Ir | Information ratio | -0.1 |
Organoclick Volatility Alert
Organoclick AB exhibits very low volatility with skewness of 1.63 and kurtosis of 7.42. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Organoclick's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Organoclick's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Organoclick Fundamentals Vs Peers
Comparing Organoclick's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Organoclick's direct or indirect competition across all of the common fundamentals between Organoclick and the related equities. This way, we can detect undervalued stocks with similar characteristics as Organoclick or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Organoclick's fundamental indicators could also be used in its relative valuation, which is a method of valuing Organoclick by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Organoclick to competition |
| Fundamentals | Organoclick | Peer Average |
| Return On Equity | -0.32 | -0.31 |
| Return On Asset | -0.1 | -0.14 |
| Profit Margin | (0.32) % | (1.27) % |
| Operating Margin | (0.27) % | (5.51) % |
| Current Valuation | 352.06 M | 16.62 B |
| Shares Outstanding | 97.95 M | 571.82 M |
| Shares Owned By Insiders | 35.49 % | 10.09 % |
| Shares Owned By Institutions | 22.34 % | 39.21 % |
| Price To Earning | (17.42) X | 28.72 X |
| Price To Book | 3.99 X | 9.51 X |
| Price To Sales | 3.07 X | 11.42 X |
| Revenue | 110.06 M | 9.43 B |
| Gross Profit | 18.51 M | 27.38 B |
| EBITDA | (14.57 M) | 3.9 B |
| Net Income | (32.69 M) | 570.98 M |
| Cash And Equivalents | 34.25 M | 2.7 B |
| Cash Per Share | 0.11 X | 5.01 X |
| Total Debt | 24.85 M | 5.32 B |
| Debt To Equity | 198.40 % | 48.70 % |
| Current Ratio | 0.69 X | 2.16 X |
| Book Value Per Share | 0.81 X | 1.93 K |
| Cash Flow From Operations | (37.69 M) | 971.22 M |
| Earnings Per Share | (0.33) X | 3.12 X |
| Target Price | 5.0 | |
| Number Of Employees | 48 | 18.84 K |
| Beta | 0.96 | -0.15 |
| Market Capitalization | 365.11 M | 19.03 B |
| Total Asset | 188.39 M | 29.47 B |
| Retained Earnings | (76 M) | 9.33 B |
| Working Capital | 30 M | 1.48 B |
| Current Asset | 52 M | 9.34 B |
| Current Liabilities | 22 M | 7.9 B |
| Z Score | 8.4 | 8.72 |
Organoclick Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Organoclick . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 847.3 | |||
| Daily Balance Of Power | (0.07) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.87 | |||
| Day Typical Price | 2.85 | |||
| Price Action Indicator | (0.05) | |||
| Period Momentum Indicator | (0.01) |
About Organoclick Buy or Sell Advice
When is the right time to buy or sell Organoclick AB? Buying financial instruments such as Organoclick Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Organoclick in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Military Industrial Thematic Idea Now
Military Industrial
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Organoclick Stock Analysis
When running Organoclick's price analysis, check to measure Organoclick's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organoclick is operating at the current time. Most of Organoclick's value examination focuses on studying past and present price action to predict the probability of Organoclick's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organoclick's price. Additionally, you may evaluate how the addition of Organoclick to your portfolios can decrease your overall portfolio volatility.